Primus Aerospace Adopts VELO3D’s Titanium AM System to Unlock the Future of Design for the Aerospace and Defense Industry
Primus Aerospace—a leading contract manufacturing partner to aerospace, defense & space OEMs—has joined the VELO3D partner network with the purchase of a Ti6Al4V Sapphire® metal additive manufacturing (AM) system.
This is the first titanium-dedicated metal 3D printer from VELO3D that will be used solely for aerospace & defense applications. Primus has identified VELO3D’s AM system as a solution for many applications they currently produce, including cube satellites, hypersonics and turbine engines. The Colorado-based company is a top-tier supplier for the leading defense primes and the majority of aerospace OEMs, including Lockheed, Boeing, Northrop Grumman, General Dynamics, and Raytheon.
“Primus is proud to be a leader in this manufacturing category,” says Gary Vaillancourt, Vice President of Engineering & Technical Sales. “Our customers require maximum performance of their aerospace-related systems and, together with VELO3D, we can redefine what is possible in manufacturing through advanced AM technology.”
The partnership with VELO3D will enable Primus Aerospace to deliver unique design freedom and highest-quality AM services to their customers. Using the VELO3D manufacturing solution, Primus is looking to unlock powerful design and manufacturing capabilities that will enable the realization of previously unattainable geometries and optimized solutions as well as the exploration of novel aerospace applications.
“Primus Aerospace is an excellent partner for us with their customer focus, commitment to innovation, and adoption of leading-edge technology,” says Benny Buller, founder and CEO of VELO3D. “Our capabilities will help them deliver to engineers and supply chain managers the part designs they want, not the limited part geometries that other commodity-AM suppliers say they can have. The synergies between our two companies will support developers of new products to optimize their designs without compromise or restraint.”
Primus Aerospace expects to take delivery of the titanium Sapphire® System in Q1 2021 and will begin offering titanium printing at their facility located in Golden, Colorado.
Learn more about the VELO3D Contract Manufacturing Partner Network. https://www.velo3d.com/partners/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005206/en/
Contact information
Media Contact for Primus:
Gary Vaillancourt
Vice President Engineering & Technical Sales
gvaillancourt@primusaero.com
Media Contact for VELO3D:
Renette Youssef
Chief Marketing Officer
press@velo3d.com
Twitter: https://twitter.com/VELO3DMetal
Facebook: https://www.facebook.com/Velo3Dinc/
LinkedIn: https://www.linkedin.com/company/velo3d/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)17.9.2025 22:46:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability1. “The European Commission’s approval of vimseltinib for TGCT is a significant milestone for Deciphera, ONO, and TGCT patients across the European Union who are in need of a non-invasive treatment option. We are excited to leverage our global commercial infrastructure to bring vimseltinib to these patients,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “We look forward to working with health authorities to ensure all eligible patients who can benefit from vimseltinib have access as quickly as p
Northern Escape Heli-Skiing Sees Global Surge in Demand as Adventurers Seek Canada’s Legendary Powder17.9.2025 19:09:00 EEST | Press release
Luxury adventure travel continues accelerating, with analysts projecting ~7.6% annual growth through 2030 [1][5]. Meanwhile, global tourism reached record highs in 2024 [2], and ski tourism is above pre-pandemic norms [3]. Northern Escape Heli-Skiing (NEH), named World’s Best Heli-Ski Operator by the World Ski Awards [4] in 2022, 2023, and 2024, continues to welcome a truly international mix of guests each winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909723150/en/ Global Appeal Post-pandemic travellers prioritize remote, nature-led adventures and privacy-forward itineraries [1][3]. Adventure tourism is on a sharp upswing globally [5], while research highlights how social media and influencer content accelerate demand for marquee mountain experiences [7]. At the same time, heli-sports are forecast to expand steadily across Canada, Europe, APAC, and South America [8]. World’s Best Heli-Ski NEH operates in BC’s Ske
Bacardi Announces Internal Leadership Moves Within People and Supply Chain Organizations17.9.2025 17:35:00 EEST | Press release
Bacardi Limited, the world’s largest privately held international spirits company, announces several internal moves, underscoring the company’s global approach to leadership development and a commitment to talent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917778482/en/ Bacardi announces new roles for Dave Ingram and Nicole Zukowski. Dave Ingram has been appointed to the role of Chief People & Business Transformation Officer, responsible for delivering the next chapter for building an organization that is fit for the future. In this role, Dave will continue to prioritize talent management, succession planning, performance management, and capability building which are core to setting a legacy of more than 163 years for the success of generations to come. Dave, a member of the Bacardi Global Leadership Team, most recently served as Chief Supply Chain Officer, where he led the end-to-end supply chain for the company’s po
Andersen Consulting Adds Collaborating Firm Charter17.9.2025 16:30:00 EEST | Press release
Andersen Consulting expands its digital transformation capabilities through a Collaboration Agreement with Charter, a Canadian consulting firm that specializes in IT strategy, managed services, and application delivery. Established in 1997, Charter delivers technology projects with a business-first mindset and deep technical expertise, offering IT advisory, cloud infrastructure, cybersecurity, application development, project delivery, and business architecture. Charter supports traditional enterprise, government, service provider, and mid-market clients with implementation, network infrastructure, and customer-facing applications—delivered through a lifecycle approach from strategy to execution. “Our goal at Charter has always been to remove the complexity from IT and help organizations move with confidence,” said Kelly Michell, president of Charter. “Our collaboration with Andersen Consulting enables us to bring our integrated, business-aligned solutions to new markets and continue d
Wildix and RoboReception’s Joint AI Rollout Eliminates Missed Calls, Unlocking £9 Million in New Patient Value Across UK Healthcare17.9.2025 16:10:00 EEST | Press release
Wildix, a global leader in AI-powered business communications solutions, and RoboReception, one of the UK’s fastest-growing healthcare software providers, today announced results from an AI rollout reshaping patient access and practice economics. Since May 2025, the joint 24/7 AI receptionist has answered over 50,000 patient calls with zero missed, converting them into £9 million in new patient revenue and returning more than 2,000 hours to clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917199595/en/ Wildix and RoboReception AI Rollout Unlocks £9M in Patient Value, Handles 50,000 Calls with Zero Missed Since May 2025 Delivered with Wildix reseller Focus CX, the rollout shows how agentic voice automation relieves frontline pressure, improves patient experience and provides measurable value. Missed calls remain one of healthcare’s hidden drains. Over a third of new patient calls go unanswered and most never c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom